Merck's Oral PCSK9 Inhibitor Could Pose A Future Threat After Early Trial Success

 
• By Jessica Merrill
  
pills versus injections
Merck's oral PCSK9 blocker shows similar efficacy to injections • Source: Alamy

More from Cardiovascular

More from Therapy Areas